News | Clinical Decision Support | March 11, 2015

Point of Care Decision Support Anticoagulation Software Helps Reduce Hospital Re-Admissions

Software is designed and developed in association with national patient safety guidelines to reduce adverse events and re-admissions

Point of Care Decision Support, anticoagulation software, PCDS AC, therapy

Image courtesy of Point of Care Decision Support

March 11, 2015 — Point of Care Anticoagulation software (PCDS AC) optimizes delivery of anticoagulation (AC) drugs and reduces adverse events associated with anticoagulation therapy. The software was designed and developed in collaboration with leading clinical thrombosis experts, and is a decision support tool that takes the complexity out of AC management by providing a real-time AC dashboard. With intuitive, predictive clinical decision support, PCDS AC transforms evidence-based guidelines into intelligent tools that measure and improve AC therapy outcomes.

PCDS AC meets the key recommendations of The Joint Commission, the Centers for Medicare and Medicaid Services (CMS) and the Anticoagulation EHR (Electronic Health Record) Task Force. The system could be beneficial in light of new target-specfic oral anticoagulants (TSOAC) drugs coming onto the market, changing AC therapy protocols and more stringent regulatory guidelines.

Key benefits and outcomes of using PCDS AC include:

Patient Safety and Cost Savings: Warfarin-related adverse drug events (myocardial infarctions, strokes, major bleeds, etc.) are reduced by consistently achieving time-in-therapeutic range (TTR) above 70 percent per CMS recommendations.

Patient Safety & Revenue Generation: The PCDS AC system brings together the ACCP Antithrombotic guidelines, risk ratings like CHA2DS2-VASc, HAS-BLED, HEMORR2HAGES, drug-drug interactions, and other evidence-based research to automatically identify high risk patients and manage their AC care end-to-end.  This also provides an opportunity to identify new patients who may benefit from proactive AC therapy and reduce their overall risk of stroke.

Patient Satisfaction: The PCDS AC system incorporates full TSOAC therapy and workflow, which allow for expanded paradigms of anticoagulant management. These new TSOAC agents require far less blood testing, which is a major benefit for patients.  In addition, the system provides data on the efficacy of TSOACs, leading to improved patient care and, ultimately, cost savings surrounding adverse events.

Fulfill CMS Meaningful Use Stages 2 & 3: Provides ability to fulfill CMS MU-2 criteria for quality of Warfarin dosing at a system level with TTR > 70 percent.  Achieves MU-3 measures by improving population health, provides decision support for high priority health conditions, and provides patient self-management tools via a mobile patient engagement application.

Point of Care Decision Support provides any healthcare organization a free, customized demonstration and business case report for its anticoagulant patient population. 

For more information: www.ptofcare.com

Related Content

A step-by-step overview of how to perform interventional CRT (I-CRT) lead placement using the coronary sinus. This image shows the Medtronic Attain Performa quadripolar lead and VivaQuad XT CRT-D system.
Feature | EP Lab | January 21, 2019 | Matthew S. McKillop, M.D., FACC, FHRS, and Seth J. Worley, M.D.
Interventional...
An implanted ICD showing its three venous leads. These multiple CRT leads can cause issues when they need to be replaced and are abandoned with new leads put over them in the SVC, which may require lead extraction.

An implanted ICD showing its three leads in the venous system. 

Feature | EP Lab | January 13, 2019 | Dave Fornell, Editor
To extract or abandon broken or infected implantable, venous...
Videos | EP Lab | January 03, 2019
This is a quick video tour of one of the dedicated...
HHS and NASA Team Up to Explore Health on Earth and in Outer Space

Image courtesy of NASA

News | EP Lab | December 14, 2018
The Department of Health and Human Services (HHS) recently entered into an interagency agreement with the National...
Technology Improvements Driving Electrophysiology Market Growth

Navik 3D Cardiac Mapping System image courtesy of APN Health.

News | EP Lab | December 10, 2018
December 10, 2018 — Electrophysiology, whil
Vagal Maneuvers With Supraventricular Tachycardia

Image courtesy of ACLS Certification Institute

Feature | EP Lab | December 05, 2018
Supraventricular tachycardia (SVT) is a common heart abnormality that presents as a fast heart rate. SVT is a generic...
Societies Publish New Guidance for Treatment of Slow, Irregular Heartbeats
News | EP Lab | November 09, 2018
The American College of Cardiology (ACC), the American Heart Association (AHA) and the Heart Rhythm Society (HRS)...
A view of the EPD Solutions catheter ablation system image guidance. It displays the catheter within a pre-acquired 3D segmented CT image. The D700 system provides a real-time lesion assessment tool that predicts transmurality and permanency of lesions, pre- and immediately post-ablation.

A view of the EPD Solutions catheter ablation system image guidance. It displays the catheter within a pre-acquired 3D segmented CT image. The D700 system provides a real-time lesion assessment tool that predicts transmurality and permanency of lesions, pre- and immediately post-ablation.

News | EP Lab | June 05, 2018
June 5, 2018 — Philips Healthcare has signed an agreement to acquire EPD Solutions, a provider of image-guidance in c
A recent study shows the Baylis NRG radiofrequency (RF) Transseptal puncture catheter has a lower incidence of embolism in EP cases.
News | EP Lab | May 21, 2018
May 21, 2018 — A recent study published in Heart and Vessels has found that the use of the Baylis Medical NR
Overlay Init